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Abstract
PURPOSE—To assess whether the implantation site of VX2 carcinoma into rabbit liver affects
successful vessel selection for transcatheter arterial interventions.
MATERIALS AND METHODS—Twenty-four New Zealand White rabbits were randomly
assigned to two groups. All implantations were performed by open laparotomy with minced tumor
cells inserted into a 16-gauge Angiocath needle. Group I rabbits (n = 12) had tumor implanted into
the left medial lobe of the liver and group II rabbits (n = 12) had tumor implanted into the left lateral
lobe. Two weeks after implantation, selective angiography was performed for subsequent
chemoembolization, which was part of a different study. Tested variables included maximum tumor
diameter, tumor feeding artery size, and tumor vascularity.
RESULTS—Successful tumor growth was achieved in all rabbits. Selective angiography was
possible in 33.3% of rabbits in group I and 66.6% of rabbits in group II (P < .05). Tumor size and
vascularity were similar between groups. Mean lengths of tumor feeder arteries from the bifurcation
of the left hepatic artery were 4.1 mm ± 1.2 in group I (left medial lobe) and 10.8 mm ± 3.0 in group
II (left lateral lobe; P < .05). The angulation of the left medial lobar artery (group I) off the left hepatic
artery was acute in eight of 12 rabbits (66.6%), but only four of 12 rabbits in group II (33.3%) showed
acute angulation of the left lateral lobar artery off the left hepatic artery (P < .05). Mean angiography
time was significantly shorter in group II.
CONCLUSIONS—For selective hepatic arterial interventions, the left lateral lobe of the liver may
be favorable as an implantation site for VX2 tumors in rabbits.
For the past several decades, rabbits have been used for experimental studies of diagnosis and
treatment of malignant liver tumors with use of VX2 carcinoma (1–5). There is no doubt that
successful tumor implantation and growth in the liver leads to successful experimental studies
and that continuous improvement of all technical aspects of the tumor implantation technique
may improve our knowledge regarding the selective use of VX2 carcinoma.
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Interventional radiologists have been using the VX2 liver model for translational interventional
oncology studies, especially for transcatheter arterial infusions, in which selective therapeutic
drug administration is desirable (2,3). During previous translational experiments (unpublished
data), we noticed that the implantation site of tumor may affect the success rate of selective
hepatic arterial interventions (2,3,6). We therefore initiated a study to investigate whether the
liver VX2 implantation site may have an impact on successfully selecting and/or super-
selecting the rabbit’s hepatic arteries and tumor feeding arteries. We focused on only the two
left lobes (medial and lateral) of the rabbit liver, as we believe the right lobes are not suitable
for transcatheter interventions because of an increased number of gastrointestinal
complications.
MATERIALS AND METHODS
Our institution’s animal care and use committee approved the study, which was part of a study
assessing the presence of necrosis after chemo-embolization with magnetic resonance imaging.
All animal care and procedures were performed in accordance with institutional guidelines.
Animal and Tumor Model
Adult New Zealand White male rabbits weighing 3.8–4.3 kg (Myrtle’s Rabbitry, Thompson
Station, Tennessee) were used. Twelve rabbits underwent VX2 tumor implantation to the left
medial lobe of liver (group I), and the same number of rabbits received VX2 tumor implantation
to the left lateral lobe of the liver (group II).
Anesthesia and Analgesia
As a premedication, a mixture of acepromazine (2.5 mg/kg; Phoenix, St. Joseph, Missouri)
and ketamine hydrochloride (44 mg/kg; Phoenix) was injected intramuscularly. Intravenous
access was secured via a marginal ear vein, and 0.1–0.2 mL (2.5–5 mg) of sodium pentobarbital
(Hospira, Lake Forest, Illinois) was administered intravenously periodically to maintain
anesthesia. Endotracheal intubation with a 3.0-mm endotracheal tube (Mallinckrodt Medical,
St. Louis, Missouri) was performed to monitor respiration rate and end-tidal CO2.
Postoperatively, analgesic buprenorphine (0.02–0.05 mg/kg) was injected intramuscularly.
Tumor Implantation
To obtain solid tumor for implantation, VX2 tumor cell suspension (approximately 1 × 107
cells, 200 µL) was injected into both thigh muscles of a carrier rabbit. Two weeks later, the
bulk of solid tumors was harvested from the carrier rabbit and put into 0.9% sodium chloride.
The abdomen of each recipient rabbit was shaved and disinfected with ethanol and povidone
iodine. The liver was exposed with a midline subxiphoid incision. In group I, the left medial
lobe of the liver was pulled out for implantation. The left lateral lobe was chosen for
implantation in group II. The minced tumor cells were packed into a 16-gauge Angiocath (2
inches long), and the thickest portion of the liver was punctured. A 0.035-inch guide wire was
then inserted inside the Angiocath to push the minced cells inside the liver. After the Angiocath
and guide wire were removed, the pierced liver capsule was then manually compressed. After
the absence of bleeding and spillage of tumor cells was confirmed, the liver was then
repositioned back to its original intraabdominal space. The abdomen was closed in two layers
(peritoneum and muscle layer followed by skin layer) with aseptic techniques. Antibiotic
ointment was applied along the suture line.
Hepatic Angiography
Under intravenous anesthesia and intubation as described, selective hepatic angiography was
performed for subsequent chemoembolization 2 weeks after the implantation of VX2
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carcinoma with a digital subtraction angiographic unit (Toshiba, Tochigi, Japan). Surgical
cutdown of the right side of the common femoral artery and insertion of a 4-F sheath (Cook)
were done to gain access into the abdominal aorta and select the hepatic artery. A 2-F catheter
with a tip in the shape of a hockey stick (JB1 catheter; Cook) was manipulated into the celiac
trunk and common hepatic artery. By performing common hepatic arteriography, hepatic
arterial anatomy and tumor staining, vascularity, size, and location were verified. Over the
0.014-inch guide wire (Transend; Boston Scientific/Medi-tech, Miami, Florida), a 2-F JB1
catheter was inserted to the tumor feeding artery. All rabbits underwent subsequent
chemoembolization of their VX2 tumor.
Tested Variables and Statistics
Successful selective catheterization was defined as catheter engagement of the tumor feeding
artery at a distance from its origin, with concurrent catheter advancement and subsequent
positioning inside the feeding artery as close to the tumor as possible. With the catheter placed
at its final position, successful selective catheterization was confirmed by angiographic
demonstration of forward arterial flow and delineation of tumor vascularity with minimal
backflow of contrast medium to more proximal arterial branches.
Qualitative variables measured included the presence or absence of successful tumor growth,
angiographic presence or absence of hypertrophic tumor feeding artery, angiographic presence
or absence of hypervascular tumor stain, and presence or absence of acute tumor feeding vessel
angulation at its origin off the left hepatic artery. Quantitative variables included maximum
tumor diameter and length of tumor feeding artery. The length of the feeding artery was
measured by drawing a straight line parallel to the course of the artery. Short tortuousities were
not taken into account. Statistical differences were tested by χ2 and Student t tests (P < .05).
RESULTS
The goal of each intervention was to get as close to the tumor as possible. Successful tumor
growth in the liver was achieved in all rabbits in both groups. Selective angiography and
chemoembolization was possible in four of 12 rabbits (33.3%) in group I and in eight of 12
rabbits in group II (66.6%; P < .05; Fig 1, Fig 2). Tumor size (1.7 cm ± 0.3 in group I, 1.8 cm
± 0.5 in group II; P > .05), presence of a hypertrophic tumor feeder vessel, and presence of a
hypervascular tumor stain were similar between groups (Table 1). However, there were
anatomic differences between the tumor feeding arteries of the two groups (Table 2). The mean
length of the tumor feeder vessel of the left medial lobar artery (group I) was significantly
shorter than that of the left lateral lobar artery (group II) as measured from the bifurcation of
the left hepatic artery, at 4.1 mm ± 1.2 versus 10.8 mm ± 3.0, respectively (P < .05). The
angulation of the left medial lobar artery (group I) at the origin off the left hepatic artery was
acute in eight of 12 rabbits (66.6%), but in group II, only four of 12 rabbits (33.3%) showed
acute angulation of the left lateral lobar artery (P < .05). Mean angiography time in group I
was significantly longer than in group II (Table 3). Moreover, the additional use of a vasodilator
was necessary in 16% of the group I rabbits.
DISCUSSION
The optimal study execution of rabbit experiments involving hepatic transcatheter arterial
manipulations is affected by the operator’s ability to successfully select or superselect the tumor
feeding vessel. Because of small size and tortuosity of rabbit hepatic arteries, successful
selective vessel catheterization is not always possible, even in the presence of a skilled and
experienced operator or when a wide range of microcatheters is available.
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The rabbit celiac artery gives rise to the splenic artery, the right gastric artery, and the common
hepatic artery (Fig 3). The common hepatic artery then passes forward and to the right, giving
the rise to the gastroduodenal artery and the caudate lobe artery. The proper hepatic artery then
forms the main hepatic artery, which bifurcates to the right and left hepatic arteries. The latter
bifurcates to the medial and lateral segmental branches. This branching pattern may be seen
in approximately 95% of cases (7). Variations also exist, such as a separate origin of the
common hepatic artery off the superior mesenteric artery or a separate origin of the left hepatic
artery off the celiac artery. In most cases, the left hepatic artery gives rise to the medial and
lateral lobe branches.
In most studies, VX2 carcinoma is implanted into the medial lobe of the liver because it is easy
to access during laparotomy and is thick enough to tolerate the tumor implantation
manipulations (1–6,8,9). However, many tumors implanted in the left medial lobe have shown
angiographically small and tortuous feeding arteries, leading to nonselective and nontargeted
intraarterial therapy, with compromised results. This angiographic appearance of the VX2 liver
tumor was thought to be an inherent characteristic of the specific tumor vascularity. An initial
nonintentional tumor implantation in the left lateral lobe revealed a more convenient
angiographic scenario of a hypervascular tumor, with a single and long hypertrophic artery,
which smoothly originated off the left hepatic artery. This initial observation led us to further
assess whether the site of VX2 tumor implantation affects the way the tumor recruits feeding
vessels and the size of these feeding vessels. Interestingly, our initial observations were
confirmed, and more importantly, there were statistically significant anatomic differences
between the two groups. In the left medial lobar artery group, the tumor feeding artery was
small and short, originating at an acute angle off the left hepatic artery. In this group, the tumor
feeding artery often showed spasm induced by catheter or guide wire manipulation, leading to
longer fluoroscopy times, additional vasodilator administration, eventual thrombosis, and
failure of the intervention. In the left lateral lobar artery group, we observed a longer single
tumor feeding vessel, which was easier to select without arterial spasm. As a result, the success
rate of selective angiography was higher than in cases of left medial lobe tumor implantation.
To our knowledge, there is a paucity of literature describing such anatomic differences that
may subsequently be exploited for transcatheter arterial interventions. We assume that these
differences are related to the rabbit hepatic arterial anatomy (7). The left medial lobar hepatic
artery is often short, whereas the left lateral lobar artery is longer. As implanted tumors receive
blood from these arteries, it is expected that tumors implanted in the lateral lobe would recruit
vessels from the longer lateral lobar artery and that tumors implanted in the medial lobe would
recruit vessels from the shorter medial lobar artery.
Our success rate in the left lateral lobe group was not 100%, despite the favorable arterial
anatomy. This may partially attributed to the use of JB1 catheters (Cook) instead of
microcatheters, which are more flexible and easier to manipulate.
According to these results, we now choose the left lateral lobe of the liver for VX2 tumor
implantation in the rabbit. The anatomic advantages of the left lateral lobar artery, combined
with fiber braided microcatheters and guide wires, may facilitate selective angiography and
chemoembolization and increase the success rate of targeted intraarterial interventions in
rabbits.
In conclusion, for selective hepatic arterial interventions in rabbits, the left lateral lobe of the
liver may be more favorable than the left medial lobe as a VX2 tumor implantation site.
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Figure 1.
Angiographic appearance of left medial lobe tumor implantation (arrow) at 2 weeks after
implantation. Because of the acute angulation and short length of the left medial lobe artery
off the left hepatic artery (a), arterial spasm was induced during catheter and guide wire
manipulations (b), and subsequent arterial selection failed. Therapeutic drug administration
was delivered nonselectively to the right lobe. (LMHA = left medial hepatic artery, LLHA =
left lateral hepatic artery, RHA = right hepatic artery, CHA = common hepatic artery, GDA =
gastroduodenal artery.)
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Figure 2.
Angiographic appearance of the left lateral lobe tumor implantation (arrow) at 2 weeks after
implantation. Because of the obtuse angulation of the left lateral lobar artery off the left hepatic
artery (a), the tumor feeding artery could be selected easily without arterial spasm, and
sufficient length of the left lateral lobar artery could prevent drug regurgitation (b). (LMHA =
left medial hepatic artery, LLHA = left lateral hepatic artery, RHA = right hepatic artery, CHA
= common hepatic artery, GDA = gastroduodenal artery.)
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Figure 3.
Illustration of rabbit hepatic arterial anatomy. (Available in color online at www.jvir.org.)
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Table 1
Angiographic Variables with Similar Results between Rabbit Groups
Variable
Group I
(n = 12)
Group II
(n = 12)
Successful tumor growth (%) 100 100
Maximal tumor diameter (cm) 1.7 ± 0.3 1.8 ± 0.5
Angiographic presence of hypertrophic tumor feeding
   artery (%)
100 100
Angiographic presence of hypervascular tumor stain (%) 100 100
J Vasc Interv Radiol. Author manuscript; available in PMC 2009 September 21.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Lee et al. Page 10
Table 2
Anatomic Differences in the Tumor-feeding Arteries between Rabbit Groups
Anatomic Characteristic
Group I
(LML Artery)
Group II
(LLL Artery)
Length of artery (mm)* 4.1 ± 1.2 10.8 ± 3.0
Acute angulation of artery* 8/12 (66.6) 4/12 (33.3)
Note.—Values presented as means ± SD where applicable. Values in parentheses are percentages. LLL = left lateral lobe; LML = left medial lobe.
*
P < .05 between groups.
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Table 3
Procedural Differences between Groups
Procedural Detail
Group I
(LML Artery)
Group II
(LLL Artery)
Angiography time* 3.5 ± 1.1 2.1 ± 1.1
Additional use of vasodilator 2/12 (16%) 0/12
Note.—Values presented as means ± SD where applicable. LLL = left lateral lobe; LML = left medial lobe.
*
P < .05 between groups.
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